Adaptive Biotechnologies Corp. (ADPT)
24.20
-0.03
(-0.12%)
USD |
NASDAQ |
Sep 11, 16:00
23.73
-0.47
(-1.94%)
After-Hours: 05:14
Adaptive Biotechnologies Market Cap : 3.849B for Sept. 11, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Market Cap Data
| Date | Value |
|---|---|
| September 11, 2026 | 3.849B |
| September 10, 2026 | 3.854B |
| September 09, 2026 | 3.884B |
| September 08, 2026 | 3.872B |
| September 04, 2026 | 3.862B |
| September 03, 2026 | 3.908B |
| September 02, 2026 | 3.922B |
| September 01, 2026 | 3.872B |
| August 31, 2026 | 3.964B |
| August 28, 2026 | 4.007B |
| August 27, 2026 | 4.206B |
| August 26, 2026 | 4.161B |
| August 25, 2026 | 4.175B |
| August 24, 2026 | 4.064B |
| August 21, 2026 | 4.134B |
| August 20, 2026 | 4.046B |
| August 19, 2026 | 4.054B |
| August 18, 2026 | 3.907B |
| August 17, 2026 | 3.940B |
| August 14, 2026 | 3.935B |
| August 13, 2026 | 3.891B |
| August 12, 2026 | 4.016B |
| August 11, 2026 | 4.039B |
| August 10, 2026 | 4.048B |
| August 07, 2026 | 3.965B |
| Date | Value |
|---|---|
| August 06, 2026 | 3.754B |
| August 05, 2026 | 3.913B |
| August 04, 2026 | 3.905B |
| August 03, 2026 | 3.676B |
| July 31, 2026 | 3.590B |
| July 30, 2026 | 3.846B |
| July 29, 2026 | 3.588B |
| July 28, 2026 | 3.582B |
| July 27, 2026 | 3.585B |
| July 24, 2026 | 3.556B |
| July 23, 2026 | 3.563B |
| July 22, 2026 | 3.505B |
| July 21, 2026 | 3.606B |
| July 20, 2026 | 3.491B |
| July 17, 2026 | 3.660B |
| July 16, 2026 | 3.529B |
| July 15, 2026 | 3.657B |
| July 14, 2026 | 3.422B |
| July 13, 2026 | 3.357B |
| July 10, 2026 | 3.363B |
| July 09, 2026 | 3.481B |
| July 08, 2026 | 3.219B |
| July 07, 2026 | 3.325B |
| July 06, 2026 | 3.433B |
| July 02, 2026 | 3.384B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Personalis, Inc. | 1.724B |
| 10X Genomics, Inc. | 8.936B |
| Alamar Biosciences, Inc. (California) | 1.935B |
| Champions Oncology, Inc. | 70.82M |
| Medpace Holdings, Inc. | 16.36B |
Market Cap Related Metrics
| PS Ratio | 12.40 |
| Price to Book Value | 26.93 |
| Price | 24.20 |
| Earnings Yield | -1.69% |